绥美凯效果好不好

Human immunodeficiency virus (HIV), also known as AIDS, is a highly harmful infectious disease that can destroy the body's immune function, leading to the occurrence of various infectious diseases and seriously threatening people's lives and health. Just one tablet a day can achieve a good therapeutic effect, effectively inhibit the virus, and is well tolerated, making it difficult to develop drug resistance.

Trimax is a drug approved for marketing in the United States in 2014. The price of the original drug is relatively high, and we learned that the Indian Emcure Pharmaceutical Company has produced a generic version of Trimax, which is low-priced and widely welcomed by patients.

Headquartered in Pune, India, Emcure is a vertically integrated pharmaceutical company with infrastructure, skills and resources on par with the best pharmaceutical companies in the world. Its advantages cover the production and research of APIs, preparations and biotechnology. Is Suimeike from India's Emcure Pharmaceutical Company effective?

Suimeikai of India's Emcure Pharmaceutical Company is a legally produced generic drug, so it is basically the same as the original drug in terms of therapeutic effects.

Suimeikai is a core drug based on DTG, an integrase inhibitor. In the real world, antiviral treatment-naïve patients treated with DTG are better than RAL (Ascent), DRV/r (darunavir), and EFV (efavirenz). ) and ATV/r (atazanavir) have a lower proportion of central nervous system-related (CNS) adverse events. Therefore, the drug safety of Trimeq, which is based on DTG integrase inhibitors, has proven to be controllable.

Currently, it has been approved in more than 100 countries and recommended by many authoritative academic institutions in Europe and the United States as a first-line treatment drug for newly treated AIDS patients. It can be seen that its therapeutic effect is significant.

Recommended related hot articles: /newsDetail/87265.html